9 results
Pulmonary Nodule
Evaluation is guided by nodule size & assessment of probability of malignancy. In addition is
diameter are called lung ... masses & should ... associated with lung ... malignancy, clinical ... Management options
Algorithm for Management of Acute Exacerbation of COPD (AECOPD)

Obtain workup for alternate diagnoses and relevant comorbidities:
Algorithm for Management ... AECOPD) Obtain workup ... ventilated • CXR, Lung ... of AECOPD: • Clinical ... #treatment #pulmonary
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
with CTD, drugs, malignancy ... Unknown • 6-7 cases ... Organizing Pneumonia - Clinical ... other processes Workup ... ILD #diagnosis #management
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
• Most common cause ... Lung Abscess - Clinical ... polyangiitis) • Malignancy ... #Abscess #pulmonary ... #differential #causes
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
Management of patients ... known or suspected malignant ... Official ATS/STS/STR Clinical ... goals of assessing lung ... Effusions #MPE #Algorithm
Malignant Hyperthermia Crisis - Guidelines for Crises in Anaesthesia
Unexplained increase in ETCO2 AND tachycardia AND increased
Malignant Hyperthermia ... other, more common causes ... hyperventilate lungs ... Checklist #Diagnosis #Management ... #Workup
Clinical Management for Three Common Causes of Shock 
HEMORRHAGIC SHOCK
 • Ensure adequate ventilation and oxygenation.
Clinical Management ... for Three Common Causes ... , traction for long ... pressure (PEEP) for pulmonary ... #Shock #Management
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
Official ATS/STS/STR Clinical ... goals of assessing lung ... #Algorithm #Effusion ... #Malignant #Management ... #Pleural #Pulmonary
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
salivary ducts Clinical ... , INC risk PE, Pulmonary ... and Arthritis Malignancy ... MALT Lymphoma • Lung ... Rheumatology #Diagnosis #Management